nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—CYP2D6—Progesterone—uterine cancer	0.0514	0.296	CbGbCtD
Lisuride—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0493	0.284	CbGbCtD
Lisuride—CYP3A4—Progesterone—uterine cancer	0.0327	0.188	CbGbCtD
Lisuride—Pericarditis—Medroxyprogesterone Acetate—uterine cancer	0.024	0.0391	CcSEcCtD
Lisuride—Myoclonus—Medroxyprogesterone Acetate—uterine cancer	0.0172	0.0281	CcSEcCtD
Lisuride—Libido increased—Medroxyprogesterone Acetate—uterine cancer	0.017	0.0278	CcSEcCtD
Lisuride—CYP2D6—Doxorubicin—uterine cancer	0.0157	0.0903	CbGbCtD
Lisuride—HTR1B—artery—uterine cancer	0.015	0.0705	CbGeAlD
Lisuride—CYP3A4—Etoposide—uterine cancer	0.0146	0.0842	CbGbCtD
Lisuride—HTR1D—artery—uterine cancer	0.0146	0.0682	CbGeAlD
Lisuride—Pulmonary fibrosis—Etoposide—uterine cancer	0.0133	0.0217	CcSEcCtD
Lisuride—Aggression—Progesterone—uterine cancer	0.013	0.0212	CcSEcCtD
Lisuride—Blood pressure increased—Progesterone—uterine cancer	0.0114	0.0187	CcSEcCtD
Lisuride—Blood pressure increased—Medroxyprogesterone Acetate—uterine cancer	0.0104	0.0169	CcSEcCtD
Lisuride—CYP3A4—Doxorubicin—uterine cancer	0.00997	0.0574	CbGbCtD
Lisuride—Disorientation—Progesterone—uterine cancer	0.00929	0.0151	CcSEcCtD
Lisuride—Disturbance in sexual arousal—Progesterone—uterine cancer	0.00824	0.0134	CcSEcCtD
Lisuride—Pericardial effusion—Epirubicin—uterine cancer	0.008	0.013	CcSEcCtD
Lisuride—Infection—Carboplatin—uterine cancer	0.00772	0.0126	CcSEcCtD
Lisuride—Pericarditis—Epirubicin—uterine cancer	0.00759	0.0124	CcSEcCtD
Lisuride—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.00747	0.0122	CcSEcCtD
Lisuride—Pericardial effusion—Doxorubicin—uterine cancer	0.0074	0.0121	CcSEcCtD
Lisuride—ADRA1D—epithelium—uterine cancer	0.00738	0.0346	CbGeAlD
Lisuride—HTR2A—artery—uterine cancer	0.00723	0.0339	CbGeAlD
Lisuride—Pericarditis—Doxorubicin—uterine cancer	0.00702	0.0115	CcSEcCtD
Lisuride—ADRA1B—renal system—uterine cancer	0.007	0.0328	CbGeAlD
Lisuride—Abdominal discomfort—Progesterone—uterine cancer	0.00688	0.0112	CcSEcCtD
Lisuride—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00688	0.0112	CcSEcCtD
Lisuride—DRD5—female reproductive system—uterine cancer	0.00684	0.0321	CbGeAlD
Lisuride—HTR2B—myometrium—uterine cancer	0.00654	0.0307	CbGeAlD
Lisuride—Weight increased—Progesterone—uterine cancer	0.00653	0.0107	CcSEcCtD
Lisuride—Weight decreased—Progesterone—uterine cancer	0.0065	0.0106	CcSEcCtD
Lisuride—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00624	0.0102	CcSEcCtD
Lisuride—DRD5—female gonad—uterine cancer	0.00622	0.0292	CbGeAlD
Lisuride—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00592	0.00966	CcSEcCtD
Lisuride—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00589	0.0096	CcSEcCtD
Lisuride—Oedema peripheral—Progesterone—uterine cancer	0.00566	0.00923	CcSEcCtD
Lisuride—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00556	0.00907	CcSEcCtD
Lisuride—ADRA1D—female reproductive system—uterine cancer	0.00548	0.0257	CbGeAlD
Lisuride—Cardiac disorder—Progesterone—uterine cancer	0.00533	0.0087	CcSEcCtD
Lisuride—Angiopathy—Progesterone—uterine cancer	0.00521	0.0085	CcSEcCtD
Lisuride—Immune system disorder—Progesterone—uterine cancer	0.00519	0.00847	CcSEcCtD
Lisuride—Mediastinal disorder—Progesterone—uterine cancer	0.00518	0.00845	CcSEcCtD
Lisuride—ADRA2C—myometrium—uterine cancer	0.00515	0.0241	CbGeAlD
Lisuride—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00513	0.00837	CcSEcCtD
Lisuride—HTR2B—uterine cervix—uterine cancer	0.00509	0.0239	CbGeAlD
Lisuride—Mental disorder—Progesterone—uterine cancer	0.00504	0.00821	CcSEcCtD
Lisuride—Malnutrition—Progesterone—uterine cancer	0.005	0.00816	CcSEcCtD
Lisuride—HTR2B—smooth muscle tissue—uterine cancer	0.00495	0.0232	CbGeAlD
Lisuride—HTR2B—decidua—uterine cancer	0.00485	0.0227	CbGeAlD
Lisuride—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00483	0.00788	CcSEcCtD
Lisuride—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00472	0.00771	CcSEcCtD
Lisuride—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0047	0.00767	CcSEcCtD
Lisuride—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00469	0.00765	CcSEcCtD
Lisuride—HTR2B—endometrium—uterine cancer	0.0046	0.0216	CbGeAlD
Lisuride—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00456	0.00744	CcSEcCtD
Lisuride—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00453	0.00739	CcSEcCtD
Lisuride—Vertigo—Progesterone—uterine cancer	0.00449	0.00733	CcSEcCtD
Lisuride—Syncope—Progesterone—uterine cancer	0.00449	0.00732	CcSEcCtD
Lisuride—Palpitations—Progesterone—uterine cancer	0.00442	0.00721	CcSEcCtD
Lisuride—Cough—Progesterone—uterine cancer	0.00437	0.00712	CcSEcCtD
Lisuride—Pleural effusion—Epirubicin—uterine cancer	0.00429	0.00699	CcSEcCtD
Lisuride—HTR1A—renal system—uterine cancer	0.00427	0.02	CbGeAlD
Lisuride—Anxiety—Progesterone—uterine cancer	0.00424	0.00692	CcSEcCtD
Lisuride—HTR2B—uterus—uterine cancer	0.00424	0.0199	CbGeAlD
Lisuride—HTR1B—female reproductive system—uterine cancer	0.00423	0.0199	CbGeAlD
Lisuride—Dry mouth—Progesterone—uterine cancer	0.00417	0.00679	CcSEcCtD
Lisuride—Confusional state—Progesterone—uterine cancer	0.00412	0.00671	CcSEcCtD
Lisuride—ADRA2A—myometrium—uterine cancer	0.00411	0.0193	CbGeAlD
Lisuride—HTR1D—female reproductive system—uterine cancer	0.0041	0.0192	CbGeAlD
Lisuride—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00407	0.00664	CcSEcCtD
Lisuride—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00407	0.00663	CcSEcCtD
Lisuride—HTR2C—female reproductive system—uterine cancer	0.00406	0.019	CbGeAlD
Lisuride—Infection—Progesterone—uterine cancer	0.00406	0.00662	CcSEcCtD
Lisuride—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00401	0.00653	CcSEcCtD
Lisuride—ADRA2C—uterine cervix—uterine cancer	0.00401	0.0188	CbGeAlD
Lisuride—Nervous system disorder—Progesterone—uterine cancer	0.004	0.00653	CcSEcCtD
Lisuride—Tachycardia—Progesterone—uterine cancer	0.00399	0.0065	CcSEcCtD
Lisuride—ADRB1—female reproductive system—uterine cancer	0.00398	0.0187	CbGeAlD
Lisuride—Pleural effusion—Doxorubicin—uterine cancer	0.00397	0.00647	CcSEcCtD
Lisuride—Hyperhidrosis—Progesterone—uterine cancer	0.00395	0.00644	CcSEcCtD
Lisuride—Anorexia—Progesterone—uterine cancer	0.00389	0.00635	CcSEcCtD
Lisuride—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00385	0.00627	CcSEcCtD
Lisuride—ADRA2C—decidua—uterine cancer	0.00382	0.0179	CbGeAlD
Lisuride—HTR2B—female reproductive system—uterine cancer	0.00381	0.0179	CbGeAlD
Lisuride—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00377	0.00616	CcSEcCtD
Lisuride—ADRA2C—renal system—uterine cancer	0.00375	0.0176	CbGeAlD
Lisuride—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00373	0.00608	CcSEcCtD
Lisuride—Insomnia—Progesterone—uterine cancer	0.00369	0.00602	CcSEcCtD
Lisuride—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00368	0.00599	CcSEcCtD
Lisuride—Dyspnoea—Progesterone—uterine cancer	0.00364	0.00594	CcSEcCtD
Lisuride—Somnolence—Progesterone—uterine cancer	0.00363	0.00592	CcSEcCtD
Lisuride—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00363	0.00592	CcSEcCtD
Lisuride—ADRA2C—endometrium—uterine cancer	0.00362	0.017	CbGeAlD
Lisuride—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00361	0.00589	CcSEcCtD
Lisuride—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00358	0.00583	CcSEcCtD
Lisuride—Decreased appetite—Progesterone—uterine cancer	0.00355	0.00579	CcSEcCtD
Lisuride—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00353	0.00575	CcSEcCtD
Lisuride—Gastrointestinal disorder—Progesterone—uterine cancer	0.00353	0.00575	CcSEcCtD
Lisuride—Fatigue—Progesterone—uterine cancer	0.00352	0.00574	CcSEcCtD
Lisuride—ADRA2C—mammalian vulva—uterine cancer	0.0035	0.0164	CbGeAlD
Lisuride—Constipation—Progesterone—uterine cancer	0.00349	0.00569	CcSEcCtD
Lisuride—HTR2B—vagina—uterine cancer	0.00345	0.0162	CbGeAlD
Lisuride—Feeling abnormal—Progesterone—uterine cancer	0.00336	0.00549	CcSEcCtD
Lisuride—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00335	0.00546	CcSEcCtD
Lisuride—ADRA2C—uterus—uterine cancer	0.00334	0.0157	CbGeAlD
Lisuride—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.0033	0.00538	CcSEcCtD
Lisuride—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00329	0.00536	CcSEcCtD
Lisuride—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00322	0.00525	CcSEcCtD
Lisuride—ADRA2A—uterine cervix—uterine cancer	0.0032	0.015	CbGeAlD
Lisuride—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.00521	CcSEcCtD
Lisuride—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.0052	CcSEcCtD
Lisuride—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00316	0.00516	CcSEcCtD
Lisuride—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00305	0.00497	CcSEcCtD
Lisuride—ADRA2A—decidua—uterine cancer	0.00304	0.0143	CbGeAlD
Lisuride—Asthenia—Progesterone—uterine cancer	0.00293	0.00478	CcSEcCtD
Lisuride—ADRA2A—endometrium—uterine cancer	0.00289	0.0136	CbGeAlD
Lisuride—Infection—Dactinomycin—uterine cancer	0.00287	0.00468	CcSEcCtD
Lisuride—ADRA2A—mammalian vulva—uterine cancer	0.0028	0.0131	CbGeAlD
Lisuride—Anorexia—Dactinomycin—uterine cancer	0.00275	0.00449	CcSEcCtD
Lisuride—HTR2A—epithelium—uterine cancer	0.00274	0.0129	CbGeAlD
Lisuride—ADRA2C—female gonad—uterine cancer	0.00273	0.0128	CbGeAlD
Lisuride—Cardiac disorder—Etoposide—uterine cancer	0.00273	0.00445	CcSEcCtD
Lisuride—ADRA2C—vagina—uterine cancer	0.00271	0.0127	CbGeAlD
Lisuride—Dizziness—Progesterone—uterine cancer	0.0027	0.0044	CcSEcCtD
Lisuride—Angiopathy—Etoposide—uterine cancer	0.00267	0.00435	CcSEcCtD
Lisuride—ADRA2A—uterus—uterine cancer	0.00266	0.0125	CbGeAlD
Lisuride—Immune system disorder—Etoposide—uterine cancer	0.00266	0.00433	CcSEcCtD
Lisuride—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00265	0.00433	CcSEcCtD
Lisuride—Mediastinal disorder—Etoposide—uterine cancer	0.00265	0.00432	CcSEcCtD
Lisuride—HTR2A—smooth muscle tissue—uterine cancer	0.00264	0.0124	CbGeAlD
Lisuride—Vomiting—Progesterone—uterine cancer	0.0026	0.00423	CcSEcCtD
Lisuride—Headache—Progesterone—uterine cancer	0.00256	0.00417	CcSEcCtD
Lisuride—HTR2A—renal system—uterine cancer	0.00254	0.0119	CbGeAlD
Lisuride—Decreased appetite—Dactinomycin—uterine cancer	0.00251	0.00409	CcSEcCtD
Lisuride—Fatigue—Dactinomycin—uterine cancer	0.00249	0.00406	CcSEcCtD
Lisuride—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00245	0.00399	CcSEcCtD
Lisuride—ADRA2A—female reproductive system—uterine cancer	0.00239	0.0112	CbGeAlD
Lisuride—Feeling abnormal—Dactinomycin—uterine cancer	0.00238	0.00388	CcSEcCtD
Lisuride—CYP3A4—renal system—uterine cancer	0.00235	0.011	CbGeAlD
Lisuride—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.00384	CcSEcCtD
Lisuride—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00378	CcSEcCtD
Lisuride—CYP2D6—renal system—uterine cancer	0.00232	0.0109	CbGeAlD
Lisuride—Vertigo—Etoposide—uterine cancer	0.0023	0.00375	CcSEcCtD
Lisuride—Cough—Etoposide—uterine cancer	0.00223	0.00364	CcSEcCtD
Lisuride—HTR2B—lymph node—uterine cancer	0.00223	0.0105	CbGeAlD
Lisuride—Dehydration—Epirubicin—uterine cancer	0.00222	0.00361	CcSEcCtD
Lisuride—ADRA2A—female gonad—uterine cancer	0.00218	0.0102	CbGeAlD
Lisuride—Orthostatic hypotension—Epirubicin—uterine cancer	0.00218	0.00355	CcSEcCtD
Lisuride—ADRA2A—vagina—uterine cancer	0.00217	0.0102	CbGeAlD
Lisuride—Confusional state—Etoposide—uterine cancer	0.00211	0.00343	CcSEcCtD
Lisuride—Infection—Etoposide—uterine cancer	0.00208	0.00338	CcSEcCtD
Lisuride—Asthenia—Dactinomycin—uterine cancer	0.00207	0.00338	CcSEcCtD
Lisuride—Dehydration—Doxorubicin—uterine cancer	0.00205	0.00334	CcSEcCtD
Lisuride—Tachycardia—Etoposide—uterine cancer	0.00204	0.00332	CcSEcCtD
Lisuride—HTR2A—female reproductive system—uterine cancer	0.00204	0.00955	CbGeAlD
Lisuride—Hyperhidrosis—Etoposide—uterine cancer	0.00202	0.00329	CcSEcCtD
Lisuride—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00201	0.00328	CcSEcCtD
Lisuride—Anorexia—Etoposide—uterine cancer	0.00199	0.00325	CcSEcCtD
Lisuride—CYP3A4—female reproductive system—uterine cancer	0.00188	0.00884	CbGeAlD
Lisuride—Weight increased—Epirubicin—uterine cancer	0.00187	0.00306	CcSEcCtD
Lisuride—Weight decreased—Epirubicin—uterine cancer	0.00186	0.00304	CcSEcCtD
Lisuride—Dyspnoea—Etoposide—uterine cancer	0.00186	0.00304	CcSEcCtD
Lisuride—Somnolence—Etoposide—uterine cancer	0.00186	0.00303	CcSEcCtD
Lisuride—CYP2D6—female reproductive system—uterine cancer	0.00185	0.0087	CbGeAlD
Lisuride—HTR2A—vagina—uterine cancer	0.00184	0.00864	CbGeAlD
Lisuride—Vomiting—Dactinomycin—uterine cancer	0.00183	0.00299	CcSEcCtD
Lisuride—Decreased appetite—Etoposide—uterine cancer	0.00182	0.00296	CcSEcCtD
Lisuride—Gastrointestinal disorder—Etoposide—uterine cancer	0.0018	0.00294	CcSEcCtD
Lisuride—Fatigue—Etoposide—uterine cancer	0.0018	0.00294	CcSEcCtD
Lisuride—Constipation—Etoposide—uterine cancer	0.00179	0.00291	CcSEcCtD
Lisuride—Sweating—Epirubicin—uterine cancer	0.00176	0.00287	CcSEcCtD
Lisuride—ADRA2C—lymph node—uterine cancer	0.00176	0.00823	CbGeAlD
Lisuride—Weight increased—Doxorubicin—uterine cancer	0.00173	0.00283	CcSEcCtD
Lisuride—Weight decreased—Doxorubicin—uterine cancer	0.00172	0.00281	CcSEcCtD
Lisuride—Feeling abnormal—Etoposide—uterine cancer	0.00172	0.00281	CcSEcCtD
Lisuride—CYP2D6—female gonad—uterine cancer	0.00169	0.00792	CbGeAlD
Lisuride—Sweating—Doxorubicin—uterine cancer	0.00163	0.00266	CcSEcCtD
Lisuride—Oedema peripheral—Epirubicin—uterine cancer	0.00162	0.00265	CcSEcCtD
Lisuride—Cardiac disorder—Epirubicin—uterine cancer	0.00153	0.00249	CcSEcCtD
Lisuride—Oedema peripheral—Doxorubicin—uterine cancer	0.0015	0.00245	CcSEcCtD
Lisuride—Asthenia—Etoposide—uterine cancer	0.0015	0.00244	CcSEcCtD
Lisuride—Angiopathy—Epirubicin—uterine cancer	0.0015	0.00244	CcSEcCtD
Lisuride—Immune system disorder—Epirubicin—uterine cancer	0.00149	0.00243	CcSEcCtD
Lisuride—Mediastinal disorder—Epirubicin—uterine cancer	0.00149	0.00242	CcSEcCtD
Lisuride—Mental disorder—Epirubicin—uterine cancer	0.00144	0.00235	CcSEcCtD
Lisuride—Malnutrition—Epirubicin—uterine cancer	0.00143	0.00234	CcSEcCtD
Lisuride—Cardiac disorder—Doxorubicin—uterine cancer	0.00142	0.00231	CcSEcCtD
Lisuride—ADRA2A—lymph node—uterine cancer	0.0014	0.00657	CbGeAlD
Lisuride—Angiopathy—Doxorubicin—uterine cancer	0.00138	0.00226	CcSEcCtD
Lisuride—Dizziness—Etoposide—uterine cancer	0.00138	0.00225	CcSEcCtD
Lisuride—Immune system disorder—Doxorubicin—uterine cancer	0.00138	0.00225	CcSEcCtD
Lisuride—Mediastinal disorder—Doxorubicin—uterine cancer	0.00137	0.00224	CcSEcCtD
Lisuride—Mental disorder—Doxorubicin—uterine cancer	0.00134	0.00218	CcSEcCtD
Lisuride—Vomiting—Etoposide—uterine cancer	0.00133	0.00217	CcSEcCtD
Lisuride—Malnutrition—Doxorubicin—uterine cancer	0.00133	0.00216	CcSEcCtD
Lisuride—Headache—Etoposide—uterine cancer	0.00131	0.00213	CcSEcCtD
Lisuride—Vertigo—Epirubicin—uterine cancer	0.00129	0.0021	CcSEcCtD
Lisuride—Syncope—Epirubicin—uterine cancer	0.00129	0.0021	CcSEcCtD
Lisuride—Palpitations—Epirubicin—uterine cancer	0.00127	0.00207	CcSEcCtD
Lisuride—Cough—Epirubicin—uterine cancer	0.00125	0.00204	CcSEcCtD
Lisuride—Anxiety—Epirubicin—uterine cancer	0.00122	0.00199	CcSEcCtD
Lisuride—Dry mouth—Epirubicin—uterine cancer	0.00119	0.00195	CcSEcCtD
Lisuride—Vertigo—Doxorubicin—uterine cancer	0.00119	0.00195	CcSEcCtD
Lisuride—Syncope—Doxorubicin—uterine cancer	0.00119	0.00194	CcSEcCtD
Lisuride—Confusional state—Epirubicin—uterine cancer	0.00118	0.00193	CcSEcCtD
Lisuride—Palpitations—Doxorubicin—uterine cancer	0.00117	0.00191	CcSEcCtD
Lisuride—Infection—Epirubicin—uterine cancer	0.00116	0.0019	CcSEcCtD
Lisuride—Cough—Doxorubicin—uterine cancer	0.00116	0.00189	CcSEcCtD
Lisuride—Nervous system disorder—Epirubicin—uterine cancer	0.00115	0.00187	CcSEcCtD
Lisuride—Tachycardia—Epirubicin—uterine cancer	0.00114	0.00186	CcSEcCtD
Lisuride—Hyperhidrosis—Epirubicin—uterine cancer	0.00113	0.00185	CcSEcCtD
Lisuride—Anxiety—Doxorubicin—uterine cancer	0.00113	0.00184	CcSEcCtD
Lisuride—Anorexia—Epirubicin—uterine cancer	0.00112	0.00182	CcSEcCtD
Lisuride—Dry mouth—Doxorubicin—uterine cancer	0.00111	0.0018	CcSEcCtD
Lisuride—Confusional state—Doxorubicin—uterine cancer	0.00109	0.00178	CcSEcCtD
Lisuride—Infection—Doxorubicin—uterine cancer	0.00108	0.00176	CcSEcCtD
Lisuride—Nervous system disorder—Doxorubicin—uterine cancer	0.00106	0.00173	CcSEcCtD
Lisuride—Insomnia—Epirubicin—uterine cancer	0.00106	0.00173	CcSEcCtD
Lisuride—Tachycardia—Doxorubicin—uterine cancer	0.00106	0.00172	CcSEcCtD
Lisuride—Hyperhidrosis—Doxorubicin—uterine cancer	0.00105	0.00171	CcSEcCtD
Lisuride—Dyspnoea—Epirubicin—uterine cancer	0.00104	0.0017	CcSEcCtD
Lisuride—Somnolence—Epirubicin—uterine cancer	0.00104	0.0017	CcSEcCtD
Lisuride—Anorexia—Doxorubicin—uterine cancer	0.00103	0.00168	CcSEcCtD
Lisuride—Decreased appetite—Epirubicin—uterine cancer	0.00102	0.00166	CcSEcCtD
Lisuride—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00101	0.00165	CcSEcCtD
Lisuride—Fatigue—Epirubicin—uterine cancer	0.00101	0.00165	CcSEcCtD
Lisuride—Constipation—Epirubicin—uterine cancer	0.001	0.00163	CcSEcCtD
Lisuride—Insomnia—Doxorubicin—uterine cancer	0.00098	0.0016	CcSEcCtD
Lisuride—Dyspnoea—Doxorubicin—uterine cancer	0.000966	0.00158	CcSEcCtD
Lisuride—Feeling abnormal—Epirubicin—uterine cancer	0.000965	0.00157	CcSEcCtD
Lisuride—Somnolence—Doxorubicin—uterine cancer	0.000963	0.00157	CcSEcCtD
Lisuride—Decreased appetite—Doxorubicin—uterine cancer	0.000942	0.00154	CcSEcCtD
Lisuride—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000935	0.00153	CcSEcCtD
Lisuride—Fatigue—Doxorubicin—uterine cancer	0.000934	0.00152	CcSEcCtD
Lisuride—Constipation—Doxorubicin—uterine cancer	0.000926	0.00151	CcSEcCtD
Lisuride—Feeling abnormal—Doxorubicin—uterine cancer	0.000893	0.00146	CcSEcCtD
Lisuride—Asthenia—Epirubicin—uterine cancer	0.00084	0.00137	CcSEcCtD
Lisuride—Asthenia—Doxorubicin—uterine cancer	0.000777	0.00127	CcSEcCtD
Lisuride—Dizziness—Epirubicin—uterine cancer	0.000774	0.00126	CcSEcCtD
Lisuride—Vomiting—Epirubicin—uterine cancer	0.000744	0.00121	CcSEcCtD
Lisuride—Headache—Epirubicin—uterine cancer	0.000733	0.0012	CcSEcCtD
Lisuride—Dizziness—Doxorubicin—uterine cancer	0.000716	0.00117	CcSEcCtD
Lisuride—Vomiting—Doxorubicin—uterine cancer	0.000689	0.00112	CcSEcCtD
Lisuride—Headache—Doxorubicin—uterine cancer	0.000679	0.00111	CcSEcCtD
